
|Articles|March 30, 2011
Comprehensive Clinical Development Finalizes Acquisition of Charles River Clinical Services
Advertisement
The increased capacity and capabilities deliver numerous benefits to support clients’ complete drug development programs, including:
- Geographic diversification allowing clients a more proximal location to conduct studies and increase service offerings from coast to coast
- Established experience in conducting radiolabeled studies
- Streamlined optimization and extensive expertise in biologics studies
- Access to leading physicians in numerous specialties including oncology, expansive patient populations and unique nuclear pharmacy capabilities, allowing for highly differentiated studies
- Specialized pharmacy services optimized for compounding, including radiolabeled compounds
- Extensive access to populations for targeting treatments for patients with Hepatitis C
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Labels That Withstand Liquid Nitrogen
3
Setting the Limits of Autonomy with Autonomous Agents for Clinical Research
4
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
5